GlucoTrack Inc. (GCTK)
NASDAQ
Closed
Oct 28, 2026
Day's Range
1.8052 wk Range
0.7460Overview - GCTK - GlucoTrack Inc.
Key Statistics
Valuation
Enterprise Value
1.11M
P/E (Trailing)
0.07
PEG Ratio
-0.00076
Price / Book
-1.18
EV / EBITDA
-0.07
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-164.44%
Return on Equity
-620.62%
Ownership
Shares Outstanding
6.55M
Float
636.27K
Short % of Shares Outstanding
12.00%
Held by Insiders
3.29%
Held by Institutions
5.19%
Price stats
Beta
0.72
50-Day Avg
5.03
200-Day Avg
23.29
Dividends
Payout Ratio
0.00%
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GCTK - GlucoTrack Inc.
Peers - GCTK - GlucoTrack Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - GCTK - GlucoTrack Inc.
About
GlucoTrack Inc. is a medical technology company focused on diabetes monitoring solutions. GlucoTrack Inc. develops devices and systems designed to measure blood glucose levels for people living with diabetes, with an emphasis on continuous monitoring and reduced reliance on traditional finger-stick testing. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
